pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-506 |
Genomic Coordinates | chrX: 147230720 - 147230843 |
Synonyms | MIRN506, hsa-mir-506, MIR506 |
Description | Homo sapiens miR-506 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-506-5p | |||||||||||||||
Sequence | 35| UAUUCAGGAAGGUGUUACUUAA |56 | |||||||||||||||
Evidence | Not_experimental | |||||||||||||||
Experiments | ||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | EIF5AL1 | ||||||||||||||||||||
Synonyms | EIF5AP1, bA342M3.3 | ||||||||||||||||||||
Description | eukaryotic translation initiation factor 5A-like 1 | ||||||||||||||||||||
Transcript | NM_001099692 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on EIF5AL1 | |||||||||||||||||||||
3'UTR of EIF5AL1 (miRNA target sites are highlighted) |
>EIF5AL1|NM_001099692|3'UTR 1 CTGGCTCCCAAGGTGGCAGTGGTGGCAGCAGTGATCCTCCGAACCTGCAGAGGCCCCCTCCCCCAGCCTGGCCTGGCTCT 81 GGCCTGGTCCTAGGTTGGACTCCTCCTACACAATTTATTTGACGTTTTATTTTGGTTTTCCCCACCCCCTCAATCTGTCA 161 GGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCGAAGCCATGGCCTTGGTGAAGCTGCCCTCCTCTTCT 241 CCCCTCACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTTAGTCTTTTTTTTTTTTTTAAATTCA 321 ATCTGGAATCAGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCCTTGGTCTGGTCCCCTGTTGC 401 CCATAGCCCTTTACCCTGAGCACCACCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTCCCCAAACCCCT 481 TTAGATGGGGAGGGAAGAAGAGGAGAGGGGAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAAGGGCCTGCCCCCATGGG 561 CTTTACCCTTCCCTGCGGGCTCTCTCCCCGACACATTTGTTAAAATCAAACCTGAATAAAACTACAAGTTTAATATGAAA 641 AAAAAAAAAAAAGAAAGAAAGACGTGTAAAATGCCAAGAACTCTAGGAAACAGGGACAAAAACACTTCAAAGAGAAAGTT 721 CATGCACTTGTTTCTGACCACCCAGGGCACCCTTCAGCACACGCTGTCTGGAGTGGCCTGAAGCAAGGAGTGTCTTGTGA 801 GGTGCAGAGGATGCAATGGGAGCAGGGTCCTGTCCCCACCCTAAAGGAGTTCACAGTTTAACGCAAATGAGAAGCCAGTG 881 AGGACATCACTACTCCTGCTGTGAACTTGGGAACTAGAAACACAAAACCTGAGTCTGGAGGGAAGCTAAGGAAGCATTCT 961 GCTCTGGAGTAGACATGAGTGCGTGTGAAGCTTCTGATCTCCCATGAGAGCAATGGGGACATGGGGCAGAATCTAAAACC 1041 CATGACTGAAAGCACCAAATTGCTAAAATGGCAATAAAGAGACATGAGGCCAAGATGGAGAAGAAGGAACCCAGGACGAG 1121 GGTCAGCCTCACATTTGGGGCTCATTTCCCTCAGTTTCCTCACTGAATTTCAGAAGGGACTAACTGAGATGCAAAGAAGC 1201 AGAGCAGCTTTTGCACCATGTGGAGGACTAGATGGAAAACAAGTAGACTGAGGGTCTGCTAGTGAAGGTGACCCCTACTG 1281 AAGTCCACTGGCTTTGGTTGGGACCCAGAAGAGTCACACGCCAGGAATAGAGGTGGACAGGAAACACCCTGACTTTTGTA 1361 GGGACTGAACCTCACTGATAACCTCAATTGCGGATGGTATGGAGGGTGTCTAGGTGTGCTAGGACCCCTGCCCATTCCCC 1441 AGAAATAGACTCCCATCTTTTCTACAGCAAGATAACGTGCTAGTAGGCCTCAATTCATTGCTAAATATTTTTAACGAGTG 1521 TCTTACATTTAGCCAAAAAGACTAGTCATGTGGCAGGAAAAATACAATGTCATATGACCAAAAGCTAAAAGACTGTGAAA 1601 ATGAATCCAGAGGTGACCCAAGCATTGAATTTAACAATGCCAGTACCTGGACCTCCGCTTGCCCCTAAAACATTACAATC 1681 AAGAATGTAGGAAGGGAAAGGAAACACGAAGATTAATCAAGCAGGAAGGACAAGCTCAGTTTTGCACCCACTGAATTTGC 1761 CACAAATATTGTGGAAAATATTCTCGGGGACATTGCAGTTGTCTACTTTGGTTGGCACATGGTTCATACAACAGTGTTTG 1841 TGTCAGTGAACATCTTACTCTTCCTCGGCAGTCTTTCTTTGCCCAGAGATTTCGCAATGACTGTTGACCTTCATCATCAC 1921 CTTTTGGACTTTGGCTTGCACTTTAGCTTCTGTAGATCTCCATGATGTAAAGAAGTATTTTAGGTCCATTTTAATTCCTG 2001 CAAAGGATAAAATCCTTCTATTTGTGTGCATATAAGTGGACCTGAGCCCTTGGTTAGGGTGTAGAGAGGAGAAGGGGAGA 2081 AACCTGAGGGCCAGAAGCTGTTCTTTCCCTTAAAAGGGCAAACTCATTTCCACACTATGGGGACTCTGACAGATAGCATA 2161 CCTTCCTGTCTATGGCTATTGGACCTGCAGGCTTTCCCCTGTAAATCCGTGTTCTGTCATTGACATTTTGTGACTGTAAG 2241 ACAGACTTGAGATAAGACATCTAGAAAACAATAATTGAACAATGATGTGAATATATTTCACACAACTGAACTGTACATTT 2321 CAACAAGGTTAAGATGGTAATTATCACGTTATACATTTTTTACCGCAGGTTAAAATGTTTCACAGGTTGAAAGGAAAGCA 2401 ACTACCTTCAGTTCTCTGAGTTCAAGAATTTGTAACATTTCACCCCCTGCTCCTTCCTGATCTTCTGTGGAGCATCTTTT 2481 TTCCATCCATGCTCTACTCAGAGCCCACTTTCCCTTCCCTGACACCAGCTTCACTGAGGCTGGTTGGAACCTAACACAAA 2561 ACATTCTCAGTAATGACTGAATTCCCACAAAGAATTCCATATAGACTGCATATGAGTTGAATCTTCTAAGACATGAAATA 2641 TTTGTTCTCTTCTTGGCTAATATGCAATGCAAATCCTGTTGCAGATGTACGTCATATACCTCTGAAATTCCTGATGTATT 2721 CAATGAAATAACATCTTTAAAGTTCTGTGTAGAATGTTTTTTTTCTGATTTCTTCACATACGATAGAAAAAAAAACCCAA 2801 AAAAACATGTACTAGGATTTCAATAGAAGCAATGGGTGATCTAAAAAGATGAAAGAGCAACCGCATGCGCCCTACAGCTA 2881 CCGCTAGATTTTATGGGGAAAGCAGCTGGCCCAGTTTGCAGCTAGGAGAAATGTCAAACACATGAAGAAATGAGAAGCAA 2961 AGAAAAACCATGAGGCATGAACATTTCATGGCAATCACGATGTCCTGGTTTGTGAGATAATGGGATAGAGGAGTAGAAAA 3041 CAAGGAGAAAGATGAGAAGGTACAAAGTGGTTCAAGTCAAACAGCTCAACTGAACTTTTCTTAATGGAATATTTAAAAAG 3121 TGGTACATTAAAAAACTTCCCCCAGTTCACATCAAAAATTCTCTCTTCAGGACTAAGTTGGGTAGAGACTGTTCAATGTG 3201 CCTAGATATCTTCAGAACTTATATATTTTCTGTTTTCTACGTATGTTGAAGGGCAGTGCCAAATGATGTGTAATTATCTA 3281 GGTTGTAAAAATAAAACATACTCCCCCTTCCCTTGAGGATAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000520547.2 | 3UTR | CAAACCUGAAUAAAACUACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000520547.2 | 3UTR | CUCUCUCCCCGACACAUUUGUUAAAAUCAAACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
76 hsa-miR-506-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT081146 | LDLR | low density lipoprotein receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT083631 | PRNP | prion protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT157309 | IKZF2 | IKAROS family zinc finger 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT172369 | LONRF1 | LON peptidase N-terminal domain and ring finger 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT175463 | ZBTB33 | zinc finger and BTB domain containing 33 | ![]() |
![]() |
2 | 2 | ||||||
MIRT178171 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT209107 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT254771 | XRCC6 | X-ray repair cross complementing 6 | ![]() |
![]() |
2 | 6 | ||||||
MIRT264771 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT309156 | FGF2 | fibroblast growth factor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT334098 | SFT2D2 | SFT2 domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT386044 | RORA | RAR related orphan receptor A | ![]() |
![]() |
2 | 2 | ||||||
MIRT453248 | FTSJ3 | FtsJ RNA methyltransferase homolog 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455924 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456349 | OLIG3 | oligodendrocyte transcription factor 3 | ![]() |
![]() |
2 | 8 | ||||||
MIRT462877 | ZXDB | zinc finger, X-linked, duplicated B | ![]() |
![]() |
2 | 2 | ||||||
MIRT465017 | LINC00598 | long intergenic non-protein coding RNA 598 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466897 | STMN1 | stathmin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467919 | SLC20A1 | solute carrier family 20 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467927 | SLC16A7 | solute carrier family 16 member 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468172 | SGPL1 | sphingosine-1-phosphate lyase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT483372 | CYP4A22 | cytochrome P450 family 4 subfamily A member 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484061 | CYP4A11 | cytochrome P450 family 4 subfamily A member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492425 | RGL2 | ral guanine nucleotide dissociation stimulator like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495350 | ATP5S | ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B) | ![]() |
![]() |
2 | 2 | ||||||
MIRT496983 | DNAJC27 | DnaJ heat shock protein family (Hsp40) member C27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT503380 | SOD2 | superoxide dismutase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT505598 | SLC38A1 | solute carrier family 38 member 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT507384 | EN2 | engrailed homeobox 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT508638 | RPL23A | ribosomal protein L23a | ![]() |
![]() |
2 | 6 | ||||||
MIRT509813 | SULT1B1 | sulfotransferase family 1B member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT509883 | ENPP6 | ectonucleotide pyrophosphatase/phosphodiesterase 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512038 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512513 | BTBD19 | BTB domain containing 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT513071 | CHST6 | carbohydrate sulfotransferase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT514049 | AGO2 | argonaute 2, RISC catalytic component | ![]() |
![]() |
2 | 6 | ||||||
MIRT516464 | RAB32 | RAB32, member RAS oncogene family | ![]() |
![]() |
2 | 4 | ||||||
MIRT523441 | GPR137C | G protein-coupled receptor 137C | ![]() |
![]() |
2 | 4 | ||||||
MIRT523957 | DYNLT1 | dynein light chain Tctex-type 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT524143 | LDHD | lactate dehydrogenase D | ![]() |
![]() |
2 | 4 | ||||||
MIRT524632 | C4orf32 | family with sequence similarity 241 member A | ![]() |
![]() |
2 | 4 | ||||||
MIRT531710 | TFEC | transcription factor EC | ![]() |
![]() |
2 | 2 | ||||||
MIRT532813 | MRPS10 | mitochondrial ribosomal protein S10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534244 | SLC16A1 | solute carrier family 16 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534328 | SHISA6 | shisa family member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT543334 | UTP14C | UTP14C, small subunit processome component | ![]() |
![]() |
2 | 2 | ||||||
MIRT545944 | ZBTB18 | zinc finger and BTB domain containing 18 | ![]() |
![]() |
2 | 4 | ||||||
MIRT549008 | CCDC6 | coiled-coil domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT549226 | BAZ2B | bromodomain adjacent to zinc finger domain 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT550121 | RPF2 | ribosome production factor 2 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT551421 | SERTM1 | serine rich and transmembrane domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556787 | KLF13 | Kruppel like factor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561372 | UBXN2B | UBX domain protein 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT561849 | NPTX1 | neuronal pentraxin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563981 | SLFN11 | schlafen family member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565747 | SERTAD3 | SERTA domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569130 | TMC5 | transmembrane channel like 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT572714 | LHX6 | LIM homeobox 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624539 | BROX | BRO1 domain and CAAX motif containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT637034 | SPTLC3 | serine palmitoyltransferase long chain base subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643213 | TYW3 | tRNA-yW synthesizing protein 3 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT646884 | PLSCR1 | phospholipid scramblase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650183 | LILRA2 | leukocyte immunoglobulin like receptor A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651561 | WISP1 | WNT1 inducible signaling pathway protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665188 | HAUS5 | HAUS augmin like complex subunit 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665466 | WDR13 | WD repeat domain 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668763 | DDR2 | discoidin domain receptor tyrosine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT680605 | ZNF611 | zinc finger protein 611 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688564 | DCAF16 | DDB1 and CUL4 associated factor 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698121 | TOPBP1 | DNA topoisomerase II binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699130 | SMNDC1 | survival motor neuron domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712282 | PPIP5K2 | diphosphoinositol pentakisphosphate kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712561 | CENPO | centromere protein O | ![]() |
![]() |
2 | 2 | ||||||
MIRT715358 | VCAM1 | vascular cell adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720209 | KCNN1 | potassium calcium-activated channel subfamily N member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT732331 | MTDH | metadherin | ![]() |
![]() |
2 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|